PAG
TEVA icon

Private Advisor Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Private Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,200
Closed -$2K – 1071
2014
Q4 		$2K Buy
+1,200
New +$66.9K ﹤0.01% 997

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Private Advisor Group's TEVA Position: Q2 2026 in Review

Private Advisor Group reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 16% in Q2 2026, selling an estimated $116K and leaving 18,399 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Private Advisor Group first reported a position in TEVA in Q1 2014 and has held it in 49 quarters since. The position peaked at $721K in Q3 2018. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Private Advisor Group held 18,399 shares of Teva Pharmaceutical Industries Limited worth $623K as of Q2 2026.
  • Private Advisor Group sold 3,489 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $116K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1638 holding.
  • Private Advisor Group first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 49 quarters since.
  • Private Advisor Group's Teva Pharmaceutical Industries Limited position peaked at $721K in Q3 2018.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.